19-11421178-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_145045.5(ODAD3):āc.1625A>Gā(p.Tyr542Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,562 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_145045.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ODAD3 | NM_145045.5 | c.1625A>G | p.Tyr542Cys | missense_variant | 12/13 | ENST00000356392.9 | NP_659482.3 | |
ODAD3 | NM_001302453.1 | c.1463A>G | p.Tyr488Cys | missense_variant | 12/13 | NP_001289382.1 | ||
ODAD3 | NM_001302454.2 | c.1445A>G | p.Tyr482Cys | missense_variant | 10/11 | NP_001289383.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ODAD3 | ENST00000356392.9 | c.1625A>G | p.Tyr542Cys | missense_variant | 12/13 | 1 | NM_145045.5 | ENSP00000348757.3 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000807 AC: 2AN: 247804Hom.: 0 AF XY: 0.00000742 AC XY: 1AN XY: 134784
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461562Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 727028
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 16, 2024 | The c.1625A>G (p.Y542C) alteration is located in exon 12 (coding exon 12) of the CCDC151 gene. This alteration results from a A to G substitution at nucleotide position 1625, causing the tyrosine (Y) at amino acid position 542 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at